Recent publications on Cancer
US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, Epling JW Jr, Kemper AR, Krist AH, Kurth AE, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Siu AL, Tseng CW. Screening for thyroid cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2017 May 9;317(18):1882-1887. doi: 10.1001/jama.2017.4011. PubMed
Lin JS, Bowles EJA, Williams SB, Morrison CC. Screening for thyroid cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017 May 9;317(18):1888-1903. doi: 10.1001/jama.2017.0562. PubMed
Reed SC, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J, Nekhlyudov L. Cancer survivors’ reported discussions with health care providers about follow-up care and receipt of written care plans. J Cancer Educ. 2017 May 8. doi: 10.1007/s13187-017-1228-1. [Epub ahead of print]. PubMed
Mendelsohn RB, Winawer S, Jammula A, Mills G, Jordan P, O'Brien MJ, Close GM, Dorfman M, Church TR, Mandelson MT, Allen J, Feld A, Kauff ND, Morgan GA, Kumar JMR, Serrano V, Bayuga-Miller S, Fischer SE, Kuk D, Zauber AG. Adenoma prevalence in blacks and whites having equal adherence to screening colonoscopy: the National Colonoscopy Study. Clin Gastroenterol Hepatol. 2017 Apr 15. pii: S1542-3565(17)30457-3. doi: 10.1016/j.cgh.2017.04.014. [Epub ahead of print]. PubMed
Green BB, Fuller S, Anderson ML, Mahoney C, Mendy P, Powell SL. A quality improvement initiative to increase colorectal cancer (CRC) screening: collaboration between a primary care clinic and research team. J Fam Med. 2017;4(3). pii: 1115. doi: 10.26420/jfammed.2017.1115. Epub 2017 Apr 5. PubMed
Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA. Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control. 2017 Mar;28(3):241-246. doi: 10.1007/s10552-017-0866-2. Epub 2017 Feb 15. PubMed
Coronado GD, Schneider JL, Petrik A, Rivelli J, Taplin S, Green BB. Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med. 2017 Feb 1. doi: 10.1007/s13142-016-0461-1. [Epub ahead of print]. PubMed
Feigelson HS, McMullen CK, Madrid S, Sterrett AT, Powers JD, Blum-Barnett E, Pawloski PA, Ziegenfuss JY, Quinn VP, Arterburn DE, Corley DA. Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors. J Cancer Surviv. 2017 Jan 13. doi: 10.1007/s11764-017-0596-1. [Epub ahead of print]. PubMed
Knerr S, Hu EY, Zeliadt SB. Incidence of neutropenia in veterans receiving lung cancer chemotherapy: a comparison of administrative coding and electronic laboratory data. eGEMS (Wash DC). 2017 Mar 13;5(1):1269. doi: 10.13063/2327-9214.1269. eCollection 2017. PubMed
Muller CJ, Robinson RF, Smith JJ, Jernigan MA, Hiratsuka V, Dillard DA, Buchwald D. Text message reminders increased colorectal cancer screening in a randomized trial with Alaska Native and American Indian people. Cancer. 2017 Apr 15;123(8):1382-1389. doi: 10.1002/cncr.30499. Epub 2016 Dec 21. PubMed
Jones SM, Ziebell R, Walker R, Nekhlyudov L, Rabin BA, Nutt S, Fujii M, Chubak J. Association of worry about cancer to benefit finding and functioning in long-term cancer survivors. Support Care Cancer. 2017 May;25(5):1417-1422. doi: 10.1007/s00520-016-3537-z. Epub 2016 Dec 15. PubMed
Singal AG, Tiro J, Li X, Adams-Huet B, Chubak J. Factors associated with hepatocellular carcinoma surveillance rates among patients with cirrhosis in a population-based integrated healthcare delivery system. J Clin Gastroenterology.2016 Nov 18. [Epub ahead of print]. PubMed
Habbema D, Weinmann S, Arbyn M, Kamineni A, Williams AE, M C M de Kok I, van Kemenade F, Field TS, van Rosmalen J, Brown ML. Harms of cervical cancer screening in the United States and the Netherlands. Int J Cancer. 2017 Mar 1;140(5):1215-1222. doi: 10.1002/ijc.30524. PubMed
Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN. Tailoring breast cancer screening intervals by breast density and risk for women aged 50 years or older: collaborative modeling of screening outcomes. Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23. PubMed
Deng D, Du Y, Ji Z, Rao K, Wu Z, Zhu Y, Coley RY. Predicting survival time for metastatic castration resistant prostate cancer:an iterative imputation approach. F1000Research 2016, 5:2672. doi 10.12688/f1000research.8628.1) PubMed
Shortreed SM, Johnson EJ, Rutter CM, Kamineni A, Wernli KJ, Chubak J. Cohort restriction based on prior enrollment: Examining potential biases in estimating cancer and mortality risk. Obs Stud. 2016 Aug;2:51-64. Epub 2016 Sep 26. PubMed
Miglioretti DL, Lee CI. Radiation-induced breast cancer. Ann Intern Med. 2016;165(6):452. doi: 10.7326/L16-0364. PubMed
Chubak J, Ziebell R, Greenlee RT, Honda S, Hornbrook MC, Epstein M, Nekhlyudov L, Pawloski PA, Ritzwoller DP, Ghai NR, Feigelson HS, Clancy HA, Doria-Rose VP, Kushi LH. The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations. Cancer Causes Control. 2016 Sep 17. [Epub ahead of print]. PubMed
Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL. Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy. JAMA Oncol. 2016 Sep 8. doi: 10.1001/jamaoncol.2016.3022. [Epub ahead of print]. PubMed
Farjah F, Halgrim S, Buist DS, Gould MK, Zeliadt SB, Loggers ET, Carrell DS. An automated method for identifying individuals with a lung nodule can be feasibly implemented across health systems. EGEMS (Wash DC). 2016 Aug 26;4(1):1254. doi: 10.13063/2327-9214.1254. eCollection 2016. PubMed
